1. Home
  2. Recruitment

Recruitment

DXB completes Phase III patient recruitment for crucial interim analysis

Next Investors Dec 15, 2022

Our Biotech Pick of the Year, Dimerix Limited (ASX: DXB), has just announced the completion of patient recruitment for the Phase 3 Interim Analysis data. This is a crucial stage in DXB's FSGS clinical trials, helping inch closer to hopefully produce their drug which helps Renal Kidney disease patients.

DXB kidney disease treatment Phase III trial officially begins

Finfeed Oct 21, 2021

Today DXB announced that the ethics approval was granted for its Phase III clinical trial on kidney disease FSGS, marking the “official start” of the trial.

Vulcan makes appointments to progress Zero Carbon Lithium Project

Finfeed Archived Jul 16, 2020

Vulcan Energy Resources (ASX:VUL) has made two key appointments to assist in progressing its Zero Carbon Lithium Project

LiveHire surges more than 30% on award of North American contract

Finfeed Archived Apr 28, 2020

LiveHire has been awarded a direct sourcing contract in North America valued at $400,000

Get expert stock analysis direct in your inbox

LiveHire wins contract worth six times average recurring revenue

Finfeed Archived Mar 31, 2020

LiveHire Limited’s (ASX: LVH) has won a contract with Queensland state government to use its talent acquisition

Get expert stock analysis direct in your inbox

Join Our
Mailing List